Egg-derived anti-SARS-CoV-2 immunoglobulin Y (IgY) with broad variant activity as intranasal prophylaxis against COVID-19
LR Frumkin, M Lucas, CL Scribner… - Frontiers in …, 2022 - frontiersin.org
COVID-19 emergency use authorizations and approvals for vaccines were achieved in
record time. However, there remains a need to develop additional safe, effective, easy-to-
produce, and inexpensive prevention to reduce the risk of acquiring SARS-CoV-2 infection.
This need is due to difficulties in vaccine manufacturing and distribution, vaccine hesitancy,
and, critically, the increased prevalence of SARS-CoV-2 variants with greater
contagiousness or reduced sensitivity to immunity. Antibodies from eggs of hens …
record time. However, there remains a need to develop additional safe, effective, easy-to-
produce, and inexpensive prevention to reduce the risk of acquiring SARS-CoV-2 infection.
This need is due to difficulties in vaccine manufacturing and distribution, vaccine hesitancy,
and, critically, the increased prevalence of SARS-CoV-2 variants with greater
contagiousness or reduced sensitivity to immunity. Antibodies from eggs of hens …
以上显示的是最相近的搜索结果。 查看全部搜索结果